1018713
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- July 13, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Baltimore, MD (United States)
Additional Details
Postmarket Adverse Drug Experience (PADE)